- Home
- FGNX vs ACON Comparison
FGNX vs ACON Comparison
Compare FGNX & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FGNX | ACON |
|---|---|---|
| Founded | 1932 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 4.4M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | FGNX | ACON |
|---|---|---|
| Price | $2.80 | $4.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 1.0M | 111.3K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,450,000.00 | $67,483.00 |
| Revenue This Year | $95.83 | $71.77 |
| Revenue Next Year | $42.41 | $80.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 144.71 | 36.91 |
| 52 Week Low | $2.30 | $5.02 |
| 52 Week High | $41.25 | $3,499.49 |
Technical Indicators
Market Signals| Indicator | FGNX | ACON |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 33.27 |
| Support Level | N/A | $5.81 |
| Resistance Level | N/A | $6.40 |
| Average True Range (ATR) | 0.00 | 0.51 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 0.00 | 4.31 |
Price Performance
Historical ComparisonAbout FGNX Fundamental Global Inc.
FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.